Heidelberg Pharma - Company -

Heidelberg Pharma at a glance:

Situated in Ladenburg, Germany
Currently with three activity areas: the development of HDP 15.0022, which is the Enhanced Pro-Drug of Clofarabine towards the clinical investigation stage, the development of the antibody-drug conjugate technology platform, and development of new models and technologies for pre-clinical profiling.

2000 square meters of laboratory space
Core competence: pre-clinical profiling of compounds destined for the treatment of cancer or inflammatory/autoimmune diseases
Pre-clinical service provider, with focus on explorative pharmacology, drug metabolism and pharmacokinetics (DMPK) analysis and molecular biology
Services offered are routine use of standard models, customized experimental designs and new solutions

The company has 45 employees, of which 33 are directly involved in R&D. Twenty employees have a PhD or MD educational degree.

"With our organization and infrastructure for the development of anti-cancer and anti-inflammatory drugs, we offer pre-clinical services, focussed on the combination of explorative pharmacology with bioanalytical studies."